| Dr Evan David Finkelstein, MD | |
|
62 Walpole St, Norwood, MA 02062-3316 | |
| (781) 769-4090 | |
| (781) 769-6485 |
| Full Name | Dr Evan David Finkelstein |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 62 Walpole St, Norwood, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316910979 | NPI | - | NPPES |
| 0187721 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 216094 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Evan David Finkelstein, MD 62 Walpole St, Norwood, MA 02062-3316 Ph: (781) 769-4090 | Dr Evan David Finkelstein, MD 62 Walpole St, Norwood, MA 02062-3316 Ph: (781) 769-4090 |
News Archive
One of the human body's protective mechanisms initiated by the TRAIL protein is massively altered in prostate cancer cells - yet the same protein seems to improve the survival prospects of patients. These outstanding results of a cooperative venture between the Clinical Program on Urological Tumours at the Medical University of Vienna and Harvard Medical School, USA, have just been published. They show that the TRAIL protein opens up the prospect to a more accurate prediction of the disease's course, as well as the opportunity to identify a new intervention point for innovative therapies in advanced prostate cancer.
Exalenz Bioscience, a leader in developing and marketing of non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced the initiation of a clinical study evaluating the potential of its BreathID test to diagnose nonalcoholic steatohepatitis (NASH).
CryoLife, Inc., a biomaterials, medical device and tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoValve® SG pulmonary human heart valve processed with the Company's proprietary SynerGraft® technology.
Increasing oxygen delivery to muscles can help athletes perform better and give them the edge needed to win elite competitions. One of the best ways to increase oxygen supply is through blood manipulation, undergoing a blood transfusion that provides extra red blood cells and boosts oxygen levels.
Patients with advanced non–small-cell lung cancer (NSCLC) whose tumor cells contain extra copies of the epidermal growth factor receptor (EGFR) gene may be more likely to respond to the drug gefitinib (Iressa), and this high gene copy number may be an effective predictor of gefitinib efficacy, according to a new study in the May 4 issue of the Journal of the National Cancer Institute.
› Verified 8 days ago
Mark R Friedman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 62 Walpole St, Norwood, MA 02062 Phone: 781-769-4090 Fax: 781-769-6485 | |
Ana Christina Groves, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 101 Vanderbilt Ave, Norwood, MA 02062 Phone: 781-551-0405 | |
Rachel N Agrin-silva, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 325 River Ridge Dr, Dedham Medical Associates - Pediatrics, Norwood, MA 02062 Phone: 781-329-1400 | |
Karen S Farbman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 800 Washington St, Norwood, MA 02062 Phone: 781-769-4000 | |
Jenna M O'connell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1177 Providence Hwy, Norwood, MA 02062 Phone: 781-329-1400 | |
Nancy P Young, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 800 Washington St, Norwood, MA 02062 Phone: 781-769-4000 | |
Pauline Pei-ling Feng, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 800 Washington St, Dept Of Pediatrics, Norwood, MA 02062 Phone: 781-769-4000 |